局部应用拉坦前列素后发生免疫性角膜移植排斥反应：2例报告
Immunologic corneal graft rejection after administration of topical latanoprost: a report of two patients.
作者信息
Nouri-Mahdavi Kouros, Javadi Mohammad-Ali, Jafarinasab Mohammad-Reza
机构信息
Jules Stein Eye Institute, University of California Los Angeles, Los Angeles, California, USA.
出版信息
J Ophthalmic Vis Res. 2011 Apr;6(2):127-30.
Abstract
PURPOSE
To report endothelial corneal graft rejection after administration of topical latanoprost eye drops.
CASE REPORT
Two eyes of two patients with a history of multiple intraocular procedures prior to penetrating keratoplasty developed endothelial graft rejection one month after administration of topical latanoprost. Cystoid macular edema developed simultaneously in one patient.
CONCLUSION
Latanoprost may trigger endothelial graft rejection in susceptible eyes.
摘要
目的
报告局部应用拉坦前列素滴眼液后发生的角膜内皮移植排斥反应。
病例报告
两名患者在穿透性角膜移植术前有多次眼内手术史，在局部应用拉坦前列素一个月后，两只眼均发生了内皮移植排斥反应。其中一名患者同时出现了黄斑囊样水肿。
结论
拉坦前列素可能会引发易感眼的内皮移植排斥反应。
相似文献
1
Immunologic corneal graft rejection after administration of topical latanoprost: a report of two patients.局部应用拉坦前列素后发生免疫性角膜移植排斥反应：2例报告
J Ophthalmic Vis Res. 2011 Apr;6(2):127-30.
2
Long-term comparison of full-bed deep lamellar keratoplasty with penetrating keratoplasty in treating corneal leucoma caused by herpes simplex keratitis.全板层深板层角膜移植与穿透性角膜移植治疗单纯疱疹病毒性角膜炎所致角膜白斑的长期比较。
Am J Ophthalmol. 2012 Feb;153(2):291-299.e2. doi: 10.1016/j.ajo.2011.07.020. Epub 2011 Oct 13.
3
[Interim results from the prospective "Erlanger Non-high-risk Penetrating Keratoplasty Study" in 207 patients].[207例患者的前瞻性“埃尔朗根非高危穿透性角膜移植术研究”中期结果]
Klin Monbl Augenheilkd. 2000 Sep;217(3):163-70. doi: 10.1055/s-2000-10340.
4
Latanoprost-associated cystoid macular edema.拉坦前列素相关的黄斑囊样水肿。
Am J Ophthalmol. 1998 Jul;126(1):134-5. doi: 10.1016/s0002-9394(98)00082-8.
5
Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study.角膜移植排斥反应的危险因素：一项前瞻性正常风险角膜移植研究的中期结果
Graefes Arch Clin Exp Ophthalmol. 2002 Jul;240(7):580-4. doi: 10.1007/s00417-002-0496-5. Epub 2002 Jun 21.
6
Cystoid macular edema associated with latanoprost use in a pseudophakic eye with a history of surgical complications.在一只具有手术并发症病史的人工晶状体眼中，使用拉坦前列素后出现的黄斑囊样水肿。
Jpn J Ophthalmol. 2003 Jan-Feb;47(1):110-2. doi: 10.1016/s0021-5155(02)00622-6.
7
Unexplained Bilateral Simultaneous Corneal Graft Rejection in a Healthy 18-Year-Old Male.一名18岁健康男性出现不明原因的双侧同时性角膜移植排斥反应。
Cureus. 2021 Apr 21;13(4):e14612. doi: 10.7759/cureus.14612.
8
Cystoid macular edema associated with preservative-free latanoprost after uncomplicated cataract surgery: case report and review of the literature.单纯性白内障手术后与无防腐剂拉坦前列素相关的黄斑囊样水肿：病例报告及文献复习
BMC Res Notes. 2017 Mar 20;10(1):127. doi: 10.1186/s13104-017-2448-5.
9
Large-diameter penetrating keratoplasty: indications and outcomes.大直径穿透性角膜移植术：适应证与结果。
Cornea. 2010 Mar;29(3):296-301. doi: 10.1097/ICO.0b013e3181b6489e.
10
Efficacy of topical cyclosporine A 2% in prevention of graft rejection in high-risk keratoplasty: a randomized controlled trial.局部环孢素 A 2%预防高危角膜移植排斥反应的疗效：一项随机对照试验。
Graefes Arch Clin Exp Ophthalmol. 2010 Aug;248(8):1167-72. doi: 10.1007/s00417-010-1388-8. Epub 2010 Apr 23.
本文引用的文献
1
Side effects associated with prostaglandin analog therapy.与前列腺素类似物疗法相关的副作用。
Surv Ophthalmol. 2008 Nov;53 Suppl1:S93-105. doi: 10.1016/j.survophthal.2008.08.004.
2
Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial.人工晶状体眼和无晶状体眼患者使用前列腺素类似物后血-房水屏障的变化：一项为期6个月的随机试验。
Arch Ophthalmol. 2005 Feb;123(2):186-92. doi: 10.1001/archopht.123.2.186.
3
Latanoprost and cystoid macular edema in high-risk aphakic or pseudophakic eyes.拉坦前列素与高危无晶状体或人工晶状体眼的黄斑囊样水肿
J Cataract Refract Surg. 2001 Sep;27(9):1397-401. doi: 10.1016/s0886-3350(01)00770-2.
4
From PGF(2alpha)-isopropyl ester to latanoprost: a review of the development of xalatan: the Proctor Lecture.从前列腺素F2α异丙酯到拉坦前列素：Xalatan（适利达）的研发历程回顾：普罗克特讲座
Invest Ophthalmol Vis Sci. 2001 May;42(6):1134-45.
5
Latanoprost and cystoid macular edema: is there a causal relation?
Curr Opin Ophthalmol. 2000 Apr;11(2):94-100. doi: 10.1097/00055735-200004000-00005.
6
Latanoprost and herpes simplex keratitis.
Am J Ophthalmol. 1999 May;127(5):602-4. doi: 10.1016/s0002-9394(99)00050-1.
7
Latanoprost as a new horizon in the medical management of glaucoma.拉坦前列素——青光眼药物治疗的新进展
Curr Opin Ophthalmol. 1996 Apr;7(2):11-7. doi: 10.1097/00055735-199604000-00003.
8
Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias.拉坦前列素会加速人工晶状体植入术后早期血-房水屏障的破坏以及血管造影性黄斑囊样水肿的发生率。
Arch Ophthalmol. 1999 Jan;117(1):34-40. doi: 10.1001/archopht.117.1.34.
9
Cystoid macular edema associated with latanoprost in aphakic and pseudophakic eyes.无晶状体眼和人工晶状体眼中与拉坦前列素相关的黄斑囊样水肿。
Am J Ophthalmol. 1998 Oct;126(4):602-4. doi: 10.1016/s0002-9394(98)00127-5.
10
Anterior uveitis associated with latanoprost.与拉坦前列素相关的前葡萄膜炎。
Am J Ophthalmol. 1998 Jul;126(1):37-41. doi: 10.1016/s0002-9394(98)00071-3.
Zotero 插件